Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study

H. I. Scher, A. Anand, D. Rathkopf, J. Shelkey, M. J. Morris, D. C. Danila, S. Larson, J. Humm, M. Fleisher, C. L. Sawyers, T. M. Beer, J. Alumkal, C. S. Higano, E. Y. Yu, M. E. Taplin, E. Efstathiou, D. Hung, M. Hirmand, L. Seely

Research output: Contribution to journalArticlepeer-review

890 Scopus citations

Fingerprint

Dive into the research topics of 'Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences